Clinical Study

The Use of Dexamethasone in Bacterial Meningitis in Children and Adults: A Retrospective Analysis

Table 2

Prognostic factors for neurological or audiological sequelae at discharge.

Neuro/audio sequel ( š‘› = 2 1 )No sequel ( š‘› = 6 6 )Odds ratio (95% CI)

Age (yr)ā€”mean Ā± SD19 Ā± 2615 Ā± 20ā€”
Malesā€”%5747ā€”
Duration symptoms before admission (hr)ā€”mean Ā± SD44 Ā± 5133 Ā± 39ā€”
Duration symptoms before admission < 24ā€‰hrsā€”no./tot. no. (%)14/21 (67)49/64 (76)0.61 (0.21ā€“1.80)
Received Dexamethasoneā€”no./tot. no. (%)16/21 (76)46/66 (70)1.39 (0.45ā€“4.32)
Received AB in last 48ā€‰hrā€”no./tot. no. (%)5/21 (24)7/65 (11)2.59 (0.72ā€“9.26)
Coexisting conditionsā€”no/tot no (%)
ā€ƒOtitis/sinusitis6/21 (28)11/66 (17)2.00 (0.66ā€“6.30)
ā€ƒPneumoniae3/21 (14)3/66 (4)3.5 (0.65ā€“18.85)
ā€ƒImmunocompromise0/215/66 (8)ā€”
Convulsions on admissionā€”no./tot. no. (%)7/21 (33)5/66 (8)6.10 (1.69ā€“22.08)
Findings on admissionā€”no./tot. no. (%)
ā€ƒNormal consciousness7/21 (33)45/64 (70)0.21 (0.074ā€“0.60)
ā€ƒGCS score < 80/113/50 (6)ā€”
ā€ƒFocal neurological signs3/21 (14)1/66 (2)10.83 (1.06ā€“110.53)
ā€ƒTemperature > 38Ā°C17/21 (81)44/65 (68)2.03 (0.61ā€“6.78)
ā€ƒTriad (neck stiffness, fever, and altered mental status)7/13 (54)9/52 (17)5.57 (1.51ā€“20.57)
ā€ƒPetechiae4/21 (19)36/66 (54)0.20 (0.060ā€“0.64)
CSF cultureā€”no./tot. no. (%)
ā€ƒS. pneumoniae14 (67)11 (17)10 (3.28ā€“30.48)
ā€ƒN. meningitidis3 (14)33 (50)0.17 (0.045ā€“0.62)
ā€ƒOther bacteria2 (10)7 (11)0.84 (0.17ā€“4.64)
ā€ƒNegative culture2 (10)15 (23)0.36 (0.075ā€“1.72)
CSF parameters
ā€ƒPositive bacterial cultureā€”no./tot. no. (%)18/21 (86)50/66 (76)1.92 (0.50ā€“7.37)
ā€ƒWBC (/mm3)ā€”mean Ā± SD2805 Ā± 48915763 Ā± 7845ā€”
ā€ƒWBC < 1000/mm3ā€”no./tot. no. (%)11/18 (61)21/64 (33)3.22 (1.09ā€“9.49)
ā€ƒProteins (mg/dL)ā€”mean Ā± SD325 Ā± 248262 Ā± 238ā€”
ā€ƒProteins > 500ā€‰mg/dLā€”no./tot. no. (%)5/18 (28)12/61 (20)1.57 (0.47ā€“5.26)
ā€ƒGlucose (mg/dL)ā€”mean Ā± SD22,2 Ā± 18,342,0 Ā± 26,3ā€”
ā€ƒGlucose < 20ā€‰mg/dLā€”no./tot. no. (%)11/18 (61)20/62 (32)3.30 (1.11ā€“9.78)
ā€ƒGlucose CSF/serum ratio (%)ā€”mean Ā± SD21 Ā± 1733 Ā± 22ā€”
ā€ƒLactate (mmol/L)ā€”mean Ā± SD9,9 Ā± 4,47,9 Ā± 6,3ā€”
ā€ƒLactate > 10ā€‰mmol/Lā€”no./tot. no. (%)10/16 (62)12/48 (25)5 (1.50ā€“16.68)
Positive blood cultureā€”no./tot. no. (%)9/20 (45)33/63 (52)0.74 (0.27ā€“2.04)
Blood parameters
ā€ƒHb (g/dL)ā€”mean Ā± SD11 Ā± 212 Ā± 2ā€”
ā€ƒPlatelets (Ɨ103/mm3)ā€”mean Ā± SD291 Ā± 141270 Ā± 136ā€”
ā€ƒCRP (mg/L)ā€”mean Ā± SD218 Ā± 134172 Ā± 128ā€”
ā€ƒCRP > 200ā€‰mg/Lā€”no./tot. no. (%)11/21 (52)23/66 (35)2.06 (0.76ā€“5.56)
ā€ƒHyponatremia in first 72uā€”no./tot. no. (%)3/21 (14)3/66 (4)3.5 (0.65ā€“18.85)
Referred from another hospitalā€”no./tot. no. (%)7/21 (33)27/66 (41)0.72 (0.26ā€“2.03)